<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="158253">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02147093</url>
  </required_header>
  <id_info>
    <org_study_id>CR-5175</org_study_id>
    <nct_id>NCT02147093</nct_id>
  </id_info>
  <brief_title>CLARITI (TM) 1Day Multifocal Contact Lenses Performance and Acceptance Evaluation</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vistakon</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vistakon</source>
  <oversight_info>
    <authority>United Kingdon: Research Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A comparative evaluation of a newly marketed multifocal contact lens with near vision
      spectacles.  The evaluation hopes to quantify the difference between the two test
      corrections.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Distance Time Controlled LogMAR Visual Acuity</measure>
    <time_frame>7 days post wear</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Near Time Controlled LogMAR Visual Acuity</measure>
    <time_frame>7 days post wear</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Distance Static LogMAR Visual Acuity</measure>
    <time_frame>7 days post wear</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Near Static LogMAR Visual Acuity</measure>
    <time_frame>7 days post wear</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Presbyopia Correction</condition>
  <arm_group>
    <arm_group_label>Near Vision Spectacles (no contact lenses)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Glasses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CLARITI 1Day</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Multifocal contact lens</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clariti IDay</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single focal contact lens</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Near Vision Spectacles (no contact lenses)</intervention_name>
    <description>Glasses</description>
    <arm_group_label>Near Vision Spectacles (no contact lenses)</arm_group_label>
    <arm_group_label>CLARITI 1Day</arm_group_label>
    <arm_group_label>Clariti IDay</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CLARITI 1Day</intervention_name>
    <description>Multifocal</description>
    <arm_group_label>Near Vision Spectacles (no contact lenses)</arm_group_label>
    <arm_group_label>CLARITI 1Day</arm_group_label>
    <arm_group_label>Clariti IDay</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Clariti 1Day</intervention_name>
    <description>Single focal contact lens</description>
    <arm_group_label>Near Vision Spectacles (no contact lenses)</arm_group_label>
    <arm_group_label>CLARITI 1Day</arm_group_label>
    <arm_group_label>Clariti IDay</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 45 years or more

          2. Spectacle or soft contact lens wearer

          3. Refraction:  best sphere (corrected for back vertex distance) -6.00D to +4.00D;
             Astigmatism - 0.00D to -0.75D;  Near addition for 40cm; Medium Add:  +1.50D to
             +2.00D;  High Add:  +2.25D to +2.50D

          4. Best spectacle corrected visual acuity of 6/9 or better in each eye

          5. Willingness to adhere to the instructions set forth in the clinical protocol

          6. Signature of the subject Informed Consent form after review of Information to
             Participant document.

        Exclusion Criteria:

          1. Systemic or ocular allergies which might interfere with contact lens wear

          2. Systemic disease which might interfere with contact lens wear

          3. Ocular disease which might interfere with contact lens wear (e.g. hypothesia,
             insufficient lacrimal secretion)

          4. Use of medication which might interfere with contact lens wear

          5. Active ocular infection

          6. Use of ocular medication

          7. Significant ocular anomaly

          8. Presence of two or more corneal scars in either eye

          9. Monovision contact lens wearers

         10. Pregnancy or lactation

         11. Any medical condition that might be prejudicial to the study

         12. Participants non-able to give consent or from a vulnerable group

         13. Infectious disease (for example, hepatitis, tuberculosis, etc.) or a contagious
             immunosuppressive disease (such as HIV, AIDS, etc.)

         14. Employees or family member of the investigational clinic (e.g. investigator,
             coordinator, technician)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jewel Baker</last_name>
    <phone>904-443-3387</phone>
    <email>jbaker51@its.jnj.com</email>
  </overall_contact>
  <location>
    <facility>
      <address>
        <city>London</city>
        <zip>SW1E6AU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 21, 2014</lastchanged_date>
  <firstreceived_date>May 21, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Presbyopia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
